CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
Rintaro Moroi, Katsuya Endo, Katsutoshi Yamamoto, Takeo Naito, Motoyuki Onodera, Masatake Kuroha, Yoshitake Kanazawa, Tomoya Kimura, Yoichi Kakuta, Atsushi Masamune, Yoshitaka Kinouchi, Tooru Shimosegawa

DOI: https://doi.org/10.5217/ir.2018.00048

Excel Download

Anti–Tumor Necrosis Factor Therapy in Crohn's Disease: More Information and More Questions About the Long Term
Clinical Gastroenterology and Hepatology. 2010;8(7):556-558   Crossref logo
Link1 Link2

Comparative Effectiveness and Safety of Anti–Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn’s Disease
Clinical Gastroenterology and Hepatology. 2016;14(8):1120-1129.e6   Crossref logo
Link1 Link2

Treatment of fistulas in Crohn's disease with infliximab anti-tumor necrosis factor antibodies
Digestive and Liver Disease. 2000;32:A8   Crossref logo
Link1 Link2

OC.08.5: Ultrasound Elasticity Imaging Predicts Therapeutic Outcome in Patients with Crohn’S Disease Treated with Anti-Tumor Necrosis Factor Antibodies
Digestive and Liver Disease. 2017;49:e98   Crossref logo
Link1 Link2

Could Early Anti-Tumor Necrosis Factor Therapy Change the Prognosis of Crohn's Disease?
Intestinal Research. 2014;12(4):263   Crossref logo
Link1

Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents
Arthritis & Rheumatism. 2011;63(7):1812-1822   Crossref logo
Link1

Ultrasound Elasticity Imaging Predicts Therapeutic Outcome in Patients with Crohn’s Disease Treated with Anti-Tumor Necrosis Factor Antibodies
Gastroenterology. 2017;152(5):S606   Crossref logo
Link1 Link2

Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor α Antibodies
PLOS ONE. 2016;11(9):e0163126   Crossref logo
Link1

A controlled trial of anti-tumor necrosis factor alpha antibody for Crohn's disease
Gastroenterology. 1997;113(3):1042-1043   Crossref logo
Link1 Link2

Long-Term Partial Remission of AutoImmune Thrombocytopenia in a Patient Treated with the Anti-Tumor Necrosis Factor-Alpha Antibody Infliximab for Refractory Fistulizing Crohn’s Disease
Digestion. 2008;78(4):195-200   Crossref logo
Link1 Link2